SMIM26: A Non-Code RNA Molecule as A Drug Target Or Biomarker

Target Name: SMIM26

NCBI ID: G388789

SMIM26

Other Name(s): Long intergenic non-protein coding RNA 493 | small integral membrane protein 26 | long intergenic non-protein coding RNA 493 | LINC00493

SMIM26: A Non-Code RNA Molecule as A Drug Target Or Biomarker

SMIM26, also known as long intergenic non-protein coding RNA 493, is a gene that has been identified as a potential drug target or biomarker. It is located on chromosome 6 and encodes a protein known as SMIM26, which is involved in various cellular processes.

SMIM26 is a non-coding RNA molecule that is transcribed from the gene located on chromosome 6. It is characterized by the presence of a stem-loop structure, which is a common feature of many non-coding RNAs. The stem-loop is responsible for the stability of the RNA molecule and is involved in its translation into a protein.

SMIM26 has been shown to play a role in various cellular processes, including cell growth, differentiation, and inflammation. It has been shown to regulate the activity of several signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway.

SMIM26 has also been shown to be involved in the development and progression of several diseases, including cancer. For example, studies have shown that high levels of SMIM26 are associated with poor prognosis in cancer patients.

Due to its involvement in various cellular processes and its potential role in disease, SMIM26 has been identified as a potential drug target or biomarker. Researchers are currently working to develop small molecules that can inhibit the activity of SMIM26 and use it as a drug or biomarker for the treatment of various diseases.

In addition to its potential as a drug or biomarker, SMIM26 also has potential as a research tool. Researchers can use it as a tool to study the function of non-coding RNAs in various cellular processes. It can also be used to identify new potential drug targets or biomarkers.

In conclusion, SMIM26 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique stem-loop structure and involvement in various cellular processes make it an attractive target for researchers. Further studies are needed to fully understand its function and potential as a drug or biomarker.

Protein Name: Small Integral Membrane Protein 26

The "SMIM26 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMIM26 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets